Gem Aromatics Ltd
Gem Aromatics Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #33 of 71 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Gem Aromatics Ltd Q3 FY26 key numbers
- Revenue
- The existing GEM facility is expected to contribute around INR400 crores by FY’28, growing from a Q2/Q3 run-rate of INR320 crores.
As stated in Gem Aromatics Ltd's Q3 FY26 earnings call transcript · published 16 Jul 2026. Reported figures, not investment advice.
The short version
GEM Aromatics targets revenue of INR1,050 to INR1,100 crores by FY’28 with an EBITDA margin of 16% to 18%. The company targets revenue of INR 1,050 to INR 1,100 crores by FY’28 with EBITDA margins of 16% to 18% (Page 19).
From Gem Aromatics Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- GEM Aromatics targets revenue of INR1,050 to INR1,100 crores by FY’28 with an EBITDA margin of 16% to 18%.
- The Dahej (Krystal) facility is expected to ramp up to 50%-60% utilization by Q1 FY’28 and potentially reach peak revenue of INR750 to INR800 crores by FY’29.
- Krystal's contribution to revenue is projected at INR650 to INR700 crores with the balance from GEM, subject to product mix adjustments.
- The existing GEM facility is expected to contribute around INR400 crores by FY’28, growing from a Q2/Q3 run-rate of INR320 crores.
- Growth is backed by capacity ramp-up at Dahej, diversification of products, and expanding into institutional customers, especially in cooling agents.
2 more points from Gem Aromatics Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Gem Aromatics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company has invested approximately INR 250 crores in the new Dahej facility (Krystal Ingredients), with INR 20-25 crores remaining to be spent.
- The Dahej facility is designed as a flexible multipurpose manufacturing platform, supporting rapid product transitions and improved asset utilization.
- The asset turnover target for the Dahej plant is 3x, aiming for INR 750 to INR 800 crores revenue by FY '29 at peak utilization.
- The ramp-up plan targets 50%-60% utilization by Q1 FY '28, with all products expected to come online by Q1 FY '27.
2 more points from Gem Aromatics Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Gem Aromatics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Q4 is historically the strongest quarter for order booking, especially from the US and export markets.
- Customers have largely depleted inventories over Q2 and Q3, leading to increased inquiries and expected order flows in Q4.
- The company anticipates a higher volume of orders compared to Q2 and Q3 but is cautious about exact numbers due to various market uncertainties.
2 more points from Gem Aromatics Ltd's call on order book
Create a free account to keep reading this call
Gem Aromatics Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹110 Cr, net profit ₹1 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Gem Aromatics Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Neochem Bio Solutions Ltd (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Thirumalai Chemicals Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran
- IVP Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector
- Gujarat Alkalies (Q3 FY26)
3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Gem Aromatics Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Gem Aromatics Ltd Q3 FY26 results?
GEM Aromatics targets revenue of INR1,050 to INR1,100 crores by FY’28 with an EBITDA margin of 16% to 18%. The company targets revenue of INR 1,050 to INR 1,100 crores by FY’28 with EBITDA margins of 16% to 18% (Page 19).
What is Gem Aromatics Ltd share price analysis?
Gem Aromatics Ltd currently shows a neutral. The stock trades at a P/E of 678.7 with a market cap of ₹964 Cr. Investors should review the full earnings analysis for detailed insights.
Is Gem Aromatics Ltd planning capital expenditure?
The company has invested approximately INR 250 crores in the new Dahej facility (Krystal Ingredients), with INR 20-25 crores remaining to be spent.
Keep Gem Aromatics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.